 Home > Active Ingredient News > Infection > Cytoskeleton disruptor sabizabulin reduces COVID-19 deaths by 55%

Cytoskeleton disruptor sabizabulin reduces COVID-19 deaths by 55%

 Last Update: 2022-05-17
 Source: Internet
 Author: User

Tags

united scientific

drugs com id

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Pharmaceutical company Veru said on Monday that its cytoskeleton-disrupting agent sabizabulin reduced deaths by 55% compared to placebo in a phase III trial in critically ill patients hospitalized with COVID-19

COVID-19 Veru said the study was stopped early on the recommendation of an independent data monitoring committee due to "overwhelming" effectiveness

Infect

An analysis of the first 150 patients found a 20 percent mortality rate in the sabizabulin-treated group compared with 45 percent in the placebo group

FDA

"The pharmacological activity of sabizabulin is independent of the type of COVID-19 variant," said Gary Barnette, Veru's chief scientific officer

According to Veru, sabizabulin represents a potential new class of drugs that target unique binding sites on microtubules to disrupt the cytoskeleton

breast cancer

Original source:

https://firstwordpharma.

https://firstwordpharma.
com/story/5545887 https://firstwordpharma.
com/story/5545887

Leave a comment here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Sodium benzoate CAS No.532-32-1

CAS No.: 532-32-1

$1380/MT FOB

Api Powder Ketoconazole 98% Powder KETOCONAZOLE API POWDER

CAS No.: 65277-42-1

Pharmacy Grade

$3-3.2/KG FOB

High Purity Trimethoprim CAS 738-70-5 for Bacterial Infections

CAS No.: 738-70-5

Chemical Grade

$3.5-4/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.